Target intelligence / Profile preview

Karyopherin subunit alpha (KPNA)

Target
KPNA
Molecular classification
Nuclear transport protein, Karyopherin, Adaptor protein
01

Overview

Karyopherin subunit alpha, commonly known as importin-alpha, is a family of adaptor proteins (KPNA1-7) that play a central role in the classical nuclear import pathway of eukaryotic cells. It functions by recognizing and binding to the nuclear localization signal (NLS) of cargo proteins in the cytoplasm, subsequently forming a trimeric complex with importin-beta1 to facilitate translocation through the nuclear pore complex. Beyond its primary role in transport, importin-alpha is involved in critical cellular processes such as mitotic spindle assembly, nuclear envelope formation, and direct gene regulation under stress conditions. In various malignancies, including lung, gastric, and breast cancers, members of this family (particularly KPNA2) are frequently overexpressed and serve as significant biomarkers for poor prognosis. Furthermore, importin-alpha is a vital host factor hijacked by numerous viruses, such as HIV-1, SARS-CoV-2, and Dengue, to transport viral proteins into the nucleus for replication. Therapeutic strategies targeting importin-alpha, using small molecules like ivermectin or peptide inhibitors, aim to block the nuclear entry of oncogenic or viral proteins, though the essential nature of its biological function presents challenges for achieving high selectivity and safety.

Other names
Importin alphaKaryopherin alphaSRP1RCH1QIP1NPI-1
02

Mechanism of action

Inhibition of the importin-alpha/beta1 nuclear import pathway by binding to the nuclear localization signal (NLS) binding site of importin-alpha, which prevents the formation of the cargo-importin complex and its subsequent translocation into the nucleus.

03

Biological functions

Nuclear importMitosis regulationGene expression regulationSpindle assemblyNuclear envelope formation
04

Disease associations

CancerInfectionInflammation
05

Safety considerations

Potential systemic toxicity due to the essential nature of nuclear transport in all eukaryotic cellsRisk of disrupting normal cellular homeostasis and signal transductionPotential for broad-spectrum side effects in non-target tissues
06

Interacting drugs

Ivermectin

4 more in the full profile.

07

Biomarkers

KPNA2 protein expressionKPNA2 mRNA levels

Beyond the preview

Go deeper on Karyopherin subunit alpha (KPNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Karyopherin subunit alpha (KPNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call